Search

Skip to main content Search Labs A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z Lab Name or Principal Investigator Centers/Institutes Advanced Imaging Research Center Cecil H. and Ida Green Center for Reproductive Biology Sciences Center for Alzh…

Skip to main content Adult Neural Stem Cells and High-grade Glioma and Glioblastoma (GBM) GBM is the most common primary brain tumor in adults with no pre-existing lower-grade lesions. The rapid clinical course of adult GBMs presents a major challenge to develop a preventive therapy. A recent study r…

Skip to main content Meet the PI Matthew Sun, M.D. Matthew Sun, MD, is an Assistant Professor in the Department of Neurosurgery. He specializes in the treatment of brain tumors with a special interest in skull base pathologies. He earned his medical degree at University of California San Francisco. H…

The Ye Lab is broadly interested in lipid-mediated signaling reactions.

Explore the previous members of the Suzanne Conzen research lab.

What the Conzen Research lab does on our down time.

Skip to main content Lab Members Hua-Kang Wu, Ph.D. Research Scientist Hua-Kang earned his Ph.D. in Immuno-hematology from the University of Tokyo, Japan. He completed his postdoctoral training in Molecular Cancer Genetics at the University of Toronto, Canada, and gained further scientific experience…

Skip to main content Photo Gallery Expression of NY-ESO-1, a cancer testis antigen, in various grades of human meningioma samples obtained from the operating room. NY-ESO-1 is a potential target of immunotherapy for meningiomas.

Evexia, mHealth, resilience gaming app

We aim to elucidate the role of the innate immune system in damage and repair following ischemic and hemorrhagic insults to the brain. We are specifically focused on innate immune drivers of secondary injury following aneurysmal subarachnoid hemorrhage and the immune response triggered by acute intracranial pressure spikes during aneurysm rupture. We also look into promoting recovery after ischemic stroke by reprogramming microglia and peripheral myeloid cells to drive repair. In addition, we are pursuing the development of therapeutics for intraarterial immunomodulation for chronic subdural hemorrhage.